Published in Cogn Behav Neurol on March 01, 2004
Medullary venous hypertension secondary to a petrous apex dural arteriovenous fistula: a case report. Case Rep Neurol (2012) 0.75
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol (2010) 3.49
MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke (2004) 2.75
A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke (2007) 2.63
Experimental treatments for acute ischaemic stroke. Lancet (2007) 1.97
Primary outcomes for resuscitation science studies: a consensus statement from the American Heart Association. Circulation (2011) 1.93
A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol (2002) 1.91
Inter-individual variability in the capacity for motor recovery after ischemic stroke. Neurorehabil Neural Repair (2007) 1.86
The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol (2007) 1.85
Reemergence of stroke deficits with midazolam challenge. Stroke (2002) 1.73
Improvement in aphasia scores after stroke is well predicted by initial severity. Stroke (2010) 1.72
Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology (2006) 1.70
Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med (2007) 1.66
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: main results. Neurology (2014) 1.65
Impact of abnormal diffusion-weighted imaging results on short-term outcome following transient ischemic attack. Arch Neurol (2007) 1.61
The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure. J Thorac Cardiovasc Surg (2009) 1.52
Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care (2012) 1.51
A theoretical model of selective cooling using intracarotid cold saline infusion in the human brain. J Appl Physiol (1985) (2006) 1.49
Conducting stroke research with an exception from the requirement for informed consent. Stroke (2003) 1.49
Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke (2005) 1.35
Improvement after constraint-induced movement therapy: recovery of normal motor control or task-specific compensation? Neurorehabil Neural Repair (2012) 1.33
Factors contributing to global cognitive impairment in heart failure: results from a population-based cohort. J Card Fail (2008) 1.28
Early imaging correlates of subsequent motor recovery after stroke. Ann Neurol (2009) 1.27
The ARUBA trial: current status, future hopes. Stroke (2010) 1.22
Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis. Diabetes Care (2005) 1.19
The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study protocol. Stroke (2013) 1.14
Stroke, cognitive deficits, and rehabilitation: still an incomplete picture. Int J Stroke (2013) 1.12
Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease. Stroke (2003) 1.11
Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain. Arterioscler Thromb Vasc Biol (2012) 1.11
Meningioma resection in the elderly: nationwide inpatient sample, 1998-2002. Neurosurgery (2005) 1.08
Neuroimaging in stroke recovery: a position paper from the First International Workshop on Neuroimaging and Stroke Recovery. Cerebrovasc Dis (2004) 1.07
Aggregate analysis of the literature for unruptured intracranial aneurysm treatment. AJNR Am J Neuroradiol (2005) 1.06
Intravascular ultrasound of symptomatic intracranial stenosis demonstrates atherosclerotic plaque with intraplaque hemorrhage: a case report. J Neuroimaging (2008) 1.06
The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease. J Neurosurg (2009) 1.04
Prediction of motor recovery using initial impairment and fMRI 48 h poststroke. Cereb Cortex (2011) 1.04
What's in a NAIM? Hashimoto encephalopathy, steroid-responsive encephalopathy associated with autoimmune thyroiditis, or nonvasculitic autoimmune meningoencephalitis? Arch Neurol (2006) 1.04
Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol (2002) 1.03
Pumps, aqueducts, and drought management: vascular physiology in vascular cognitive impairment. Stroke (2010) 1.02
Vascular endothelial sampling and analysis of gene transcripts: a new quantitative approach to monitor vascular inflammation. J Appl Physiol (1985) (2007) 1.02
Factors associated with academic radiology research productivity. Radiology (2005) 1.01
Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. J Neurosurg (2009) 1.00
Impact of delayed transfer of critically ill stroke patients from the Emergency Department to the Neuro-ICU. Neurocrit Care (2010) 0.99
Statins and cerebral hemodynamics. J Cereb Blood Flow Metab (2012) 0.98
The contribution of HIV infection to intracranial arterial remodeling: a pilot study. Neuropathology (2012) 0.97
Association of low ejection fraction with impaired verbal memory in older patients with heart failure. Arch Neurol (2011) 0.97
Multimodal early rehabilitation and predictors of outcome in survivors of severe traumatic brain injury. J Trauma (2008) 0.96
Neurocognitive dysfunction in adult moyamoya disease. J Neurol (2009) 0.96
Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms. Int J Stroke (2011) 0.94
Trends in the hospitalization of ischemic stroke in the United States, 1998-2007. Int J Stroke (2011) 0.94
The functional relevance of cerebral hemodynamics: why blood flow matters to the injured and recovering brain. Curr Opin Neurol (2004) 0.94
Cerebral blood flow affects dose requirements of intracarotid propofol for electrocerebral silence. Anesthesiology (2006) 0.94
Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: a retrospective case report series. J Neurosurg Anesthesiol (2002) 0.92
Endovascular recanalization therapy in acute ischemic stroke. Stroke (2005) 0.92
Complications of modern diagnostic cerebral angiography in an academic medical center. J Vasc Interv Radiol (2009) 0.92
Incidence and treatment patterns in hospitalizations for malignant spinal cord compression in the United States, 1998-2006. Int J Radiat Oncol Biol Phys (2010) 0.92
Neurobehavioral differences in superselective Wada testing with amobarbital versus lidocaine. AJNR Am J Neuroradiol (2003) 0.92
Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab (2009) 0.91
Hemodynamic impairment as a stimulus for functional brain reorganization. J Cereb Blood Flow Metab (2006) 0.90
GABAergic but not anti-cholinergic agents re-induce clinical deficits after stroke. J Neurol Sci (2010) 0.90
Endoglin deficiency in bone marrow is sufficient to cause cerebrovascular dysplasia in the adult mouse after vascular endothelial growth factor stimulation. Stroke (2013) 0.90
Impact of acute ischemic stroke treatment in patients >80 years of age: the specialized program of translational research in acute stroke (SPOTRIAS) consortium experience. Stroke (2012) 0.90
Cerebrovascular reactivity and cerebral autoregulation in normal subjects. J Neurol Sci (2009) 0.89
Clinical utility of quantitative cerebral blood flow measurements during internal carotid artery test occlusions. Neurosurgery (2002) 0.89
Midazolam challenge reinduces neurological deficits after transient ischemic attack. Stroke (2003) 0.89
Intra-arterial drug delivery: a concise review. J Neurosurg Anesthesiol (2007) 0.88
Poor survival after cardiac arrest resuscitation: a self-fulfilling prophecy or biologic destiny?*. Crit Care Med (2012) 0.88
Clinical and analytical considerations in the study of health status in device trials for heart failure. J Card Fail (2005) 0.87
Transfemoral catheterization of carotid arteries with real-time MR imaging guidance in pigs. Radiology (2004) 0.86
Effect of diabetes on brain structure: the action to control cardiovascular risk in diabetes MR imaging baseline data. Radiology (2014) 0.86
A case of progressive apraxia of speech in pathologically verified Alzheimer disease. Cogn Behav Neurol (2007) 0.86
Reducing cerebral blood flow increases the duration of electroencephalographic silence by intracarotid thiopental. Anesth Analg (2005) 0.86
Cerebrovascular carbon dioxide reactivity and delayed cerebral ischemia after subarachnoid hemorrhage. Arch Neurol (2010) 0.85
Evaluation of computed tomography angiography plaque thickness measurements in high-grade carotid artery stenosis. Stroke (2014) 0.85
Reliability, asymmetry, and age influence on dynamic cerebral autoregulation measured by spontaneous fluctuations of blood pressure and cerebral blood flow velocities in healthy individuals. J Neuroimaging (2013) 0.85
Feasibility of stent placement in carotid arteries with real-time MR imaging guidance in pigs. Radiology (2004) 0.84
Contrast extravasation on computed tomographic angiography mimicking a basilar artery aneurysm in angiogram-negative subarachnoid hemorrhage: report of 2 cases. Neurosurgery (2012) 0.84
Comparison of Non-invasive and Invasive Arterial Blood Pressure Measurement for Assessment of Dynamic Cerebral Autoregulation. Neurocrit Care (2014) 0.83
Histopathological evaluation of middle cerebral artery after percutaneous intracranial transluminal angioplasty. Stroke (2003) 0.83
Clinical utility of quantitative magnetic resonance angiography in the assessment of the underlying pathophysiology in a variety of cerebrovascular disorders. Eur J Radiol (2011) 0.83
Moving beyond luminal stenosis: imaging strategies for stroke prevention in asymptomatic carotid stenosis. Cerebrovasc Dis (2015) 0.83
Hypoperfusion without stroke alters motor activation in the opposite hemisphere. Ann Neurol (2004) 0.82
Safety of thrombolysis in patients over the age of 80. Neurologist (2012) 0.82